Integra LifeSciences IART Specialty Surgery — Cost of goods sold
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's specialty surgery — cost of goods sold.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Integra LifeSciences's specialty surgery — cost of goods sold?
- Integra LifeSciences (IART) reported specialty surgery — cost of goods sold of $110.48M in Q1 2026.
- What does specialty surgery — cost of goods sold mean?
- This represents the direct costs attributable to the production and delivery of medical products within the Specialty Surgery segment. Monitoring this metric is essential for assessing manufacturing efficiency and the direct impact of supply chain costs on segment-level gross margins.